SE8105657L - Mikrobiell framstellning av humanfibroblastinterferon - Google Patents

Mikrobiell framstellning av humanfibroblastinterferon

Info

Publication number
SE8105657L
SE8105657L SE8105657A SE8105657A SE8105657L SE 8105657 L SE8105657 L SE 8105657L SE 8105657 A SE8105657 A SE 8105657A SE 8105657 A SE8105657 A SE 8105657A SE 8105657 L SE8105657 L SE 8105657L
Authority
SE
Sweden
Prior art keywords
interferon
human fibroblast
microbial preparation
fibroblast interferon
fibroplast
Prior art date
Application number
SE8105657A
Other languages
Unknown language ( )
English (en)
Swedish (sv)
Inventor
Norman Goeddel D Van
R Crea
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26886463&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE8105657(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of SE8105657L publication Critical patent/SE8105657L/

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
SE8105657A 1980-09-25 1981-09-24 Mikrobiell framstellning av humanfibroblastinterferon SE8105657L (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19079980A 1980-09-25 1980-09-25
US29189281A 1981-08-11 1981-08-11

Publications (1)

Publication Number Publication Date
SE8105657L true SE8105657L (sv) 1982-03-26

Family

ID=26886463

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8105657A SE8105657L (sv) 1980-09-25 1981-09-24 Mikrobiell framstellning av humanfibroblastinterferon

Country Status (33)

Country Link
US (1) US5460811A (cg-RX-API-DMAC10.html)
EP (1) EP0048970A3 (cg-RX-API-DMAC10.html)
AT (1) AT380694B (cg-RX-API-DMAC10.html)
AU (1) AU582110B2 (cg-RX-API-DMAC10.html)
BR (1) BR8106137A (cg-RX-API-DMAC10.html)
CA (1) CA1341569C (cg-RX-API-DMAC10.html)
CH (2) CH656388A5 (cg-RX-API-DMAC10.html)
DD (3) DD209652A5 (cg-RX-API-DMAC10.html)
DE (1) DE3138096A1 (cg-RX-API-DMAC10.html)
DK (1) DK423381A (cg-RX-API-DMAC10.html)
ES (3) ES505742A0 (cg-RX-API-DMAC10.html)
FI (1) FI812993L (cg-RX-API-DMAC10.html)
FR (1) FR2490675B1 (cg-RX-API-DMAC10.html)
GB (1) GB2098996B (cg-RX-API-DMAC10.html)
GR (1) GR81946B (cg-RX-API-DMAC10.html)
HK (1) HK43686A (cg-RX-API-DMAC10.html)
IE (1) IE51679B1 (cg-RX-API-DMAC10.html)
IL (1) IL63916A0 (cg-RX-API-DMAC10.html)
IT (1) IT1139487B (cg-RX-API-DMAC10.html)
KE (1) KE3630A (cg-RX-API-DMAC10.html)
LU (1) LU83648A1 (cg-RX-API-DMAC10.html)
MC (1) MC1423A1 (cg-RX-API-DMAC10.html)
MT (1) MTP900B (cg-RX-API-DMAC10.html)
MY (1) MY8600634A (cg-RX-API-DMAC10.html)
NL (1) NL8104400A (cg-RX-API-DMAC10.html)
NO (1) NO813248L (cg-RX-API-DMAC10.html)
NZ (1) NZ198445A (cg-RX-API-DMAC10.html)
OA (1) OA06908A (cg-RX-API-DMAC10.html)
PL (1) PL233194A1 (cg-RX-API-DMAC10.html)
PT (1) PT73728B (cg-RX-API-DMAC10.html)
SE (1) SE8105657L (cg-RX-API-DMAC10.html)
YU (1) YU44835B (cg-RX-API-DMAC10.html)
ZW (1) ZW23981A1 (cg-RX-API-DMAC10.html)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK33181A (da) * 1980-02-06 1981-08-07 Searle & Co Fremgangsmaade til fremstilling af et interferonlignende protein
ZA811368B (en) * 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
AU564690B2 (en) 1980-04-03 1987-08-20 Biogen Idec Ma Inc. Process for producing human fibroblast interferon-like polypeptides using recombinant dna
DE3176011D1 (en) * 1980-06-12 1987-04-23 Japan Found Cancer Plasmid
DK489481A (da) * 1980-11-10 1982-05-11 Searle & Co Plasmidvektor og frmgangsmaade til fremstilling deraf
NZ199722A (en) * 1981-02-25 1985-12-13 Genentech Inc Dna transfer vector for expression of exogenous polypeptide in yeast;transformed yeast strain
JPS58110600A (ja) * 1981-12-25 1983-07-01 Kyowa Hakko Kogyo Co Ltd ヒトβ型インタ−フエロン遺伝子を含む組みかえ体プラスミド
US5827694A (en) * 1982-03-08 1998-10-27 Genentech, Inc. DNA encoding non-human animal interferons, vectors and hosts therefor, and recombinant production of IFN polypeptides
US6432677B1 (en) 1982-03-08 2002-08-13 Genentech, Inc. Non-human animal interferons
IE54592B1 (en) * 1982-03-08 1989-12-06 Genentech Inc Anumal interferons, processes involved in their production, compositions containing them, dna sequences coding therefor and espression vehicles containing such sequences and cells transformed thereby
US4775622A (en) * 1982-03-08 1988-10-04 Genentech, Inc. Expression, processing and secretion of heterologous protein by yeast
AU575301B2 (en) * 1982-10-08 1988-07-28 Juridical Foundation, Japanese Foundation For Cancer Research Novel vector
US5831023A (en) * 1982-11-01 1998-11-03 Genentech, Inc. Recombinant animal interferon polypeptides
US4512922A (en) * 1982-12-22 1985-04-23 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4620948A (en) * 1982-12-22 1986-11-04 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
GR79124B (cg-RX-API-DMAC10.html) * 1982-12-22 1984-10-02 Genentech Inc
US4511502A (en) * 1982-12-22 1985-04-16 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4599197A (en) * 1982-12-22 1986-07-08 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4518526A (en) * 1982-12-22 1985-05-21 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US5683688A (en) 1984-05-31 1997-11-04 Genentech, Inc. Unglycosylated recombinant human lymphotoxin polypeptides and compositions
GB8414354D0 (en) * 1984-06-05 1984-07-11 Biogen Nv Purifying protein
ATE47864T1 (de) * 1984-08-27 1989-11-15 Genentech Inc Verschiedenartige familie von menschlichen leukozyten-interferonen, zusammensetzungen, die diese enthalten, verfahren zu ihrer herstellung, sowie dna und transfektierte wirte hierfuer.
US5231176A (en) * 1984-08-27 1993-07-27 Genentech, Inc. Distinct family DNA encoding of human leukocyte interferons
US4680262A (en) * 1984-10-05 1987-07-14 Genentech, Inc. Periplasmic protein recovery
US5618920A (en) 1985-11-01 1997-04-08 Xoma Corporation Modular assembly of antibody genes, antibodies prepared thereby and use
EP0237019A3 (en) * 1986-03-14 1988-03-09 Toray Industries, Inc. Interferon conjugate and production thereof using recombinant gene
GB9022543D0 (en) * 1990-10-17 1990-11-28 Wellcome Found Antibody production
FR2686899B1 (fr) 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
US20050002902A1 (en) * 1995-12-28 2005-01-06 Liming Yu Hybrid with interferon-alpha and an immunoglobulin Fc for treatment of tumors and viral infections
US5723125A (en) * 1995-12-28 1998-03-03 Tanox Biosystems, Inc. Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide
US20030026779A1 (en) * 1999-10-15 2003-02-06 Liming Yu Treatment of tumors and viral infections with a hybrid conjugate of interferon and an immunoglobulin Fc
US6713609B1 (en) * 1996-07-16 2004-03-30 Genentech, Inc. Monoclonal antibodies to type I interferon receptor
JP3576819B2 (ja) 1997-07-30 2004-10-13 キヤノン株式会社 情報処理装置及び印刷制御方法並びに記憶媒体
US20030018174A1 (en) * 1997-10-06 2003-01-23 Genentech, Inc. Monoclonal antibodies to IFNAR2
WO2000056924A2 (en) * 1999-03-24 2000-09-28 Genset Genomic sequence of the purh gene and purh-related biallelic markers
EP1803730A1 (en) 2000-04-12 2007-07-04 Human Genome Sciences, Inc. Albumin fusion proteins
EP1351707B9 (en) * 2001-01-09 2012-01-25 Baylor Research Institute Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays
KR101271635B1 (ko) * 2001-12-21 2013-06-12 휴먼 게놈 사이언시즈, 인코포레이티드 알부민 융합 단백질
EP2277910A1 (en) 2001-12-21 2011-01-26 Human Genome Sciences, Inc. Albumin fusion proteins
CN102319437B (zh) 2002-12-26 2017-10-13 山景医药公司 具有增强的生物学效用的干扰素‑β的聚合物缀合物
JP2006519170A (ja) * 2002-12-26 2006-08-24 マウンテン ビュー ファーマシューティカルズ，インコーポレイテッド サイトカイン、ケモカイン、増殖因子、ポリペプチドホルモン、およびレセプター結合活性が保存されたそのアンタゴニストのポリマー結合体
EP1594530A4 (en) 2003-01-22 2006-10-11 Human Genome Sciences Inc HYBRID PROTEINS OF ALBUMIN
NZ548255A (en) 2004-02-02 2010-10-29 Ambrx Inc Modified human interferon polypeptides and their uses
BRPI0613306A2 (pt) * 2005-06-22 2010-12-28 Genentech Inc anticorpos isolados, polipeptìdeos imunoglobulina, anticorpo ifnar2, molécula de acido nucléico, célula hospedeira, linhagem celular, método de produção do anticorpo, composição, método para diagnosticar a presença de ifnar2, método de tratamento de uma doença e métodos
NZ586947A (en) 2008-02-08 2012-11-30 Ambrx Inc Modified leptin polypeptides and their uses

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU257278A (en) * 1977-11-08 1984-02-29 Genentech Inc Process for obtaining a recombinat clone carrier
US4411994A (en) * 1978-06-08 1983-10-25 The President And Fellows Of Harvard College Protein synthesis
IN150740B (cg-RX-API-DMAC10.html) * 1978-11-24 1982-12-04 Hoffmann La Roche
US4332892A (en) * 1979-01-15 1982-06-01 President And Fellows Of Harvard College Protein synthesis
US4262090A (en) * 1979-06-04 1981-04-14 Cetus Corporation Interferon production
US4342832A (en) * 1979-07-05 1982-08-03 Genentech, Inc. Method of constructing a replicable cloning vehicle having quasi-synthetic genes
US4289689A (en) * 1980-03-14 1981-09-15 Hoffmann-La Roche Inc. Preparation of homogeneous human fibroblast interferon
ZA803943B (en) * 1979-07-31 1981-06-24 Hoffmann La Roche Homogeneous fibroblast interferon and method for manufacture thereof
AU538665B2 (en) * 1979-10-30 1984-08-23 Juridical Foundation, Japanese Foundation For Cancer Research Human interferon dna
IL58765A (en) * 1979-11-21 1986-09-30 Yeda Res & Dev Process for the production of essentially pure messenger rna of human fibroblast interferon and process for the production of interferon beta
US4418149A (en) * 1980-01-10 1983-11-29 President And Fellows Of Harvard College Fused hybrid gene
GB2068970B (en) * 1980-02-06 1983-06-22 Searle & Co Recombinant dna technique for the preparation of a protein resembling human interferon
DK33181A (da) * 1980-02-06 1981-08-07 Searle & Co Fremgangsmaade til fremstilling af et interferonlignende protein
DE3005843A1 (de) * 1980-02-16 1981-09-10 Hoechst Ag, 6000 Frankfurt Genprodukt eines hoeheren organismus aus einem dieses gen enthaltenden mikroorganismus
AU564690B2 (en) * 1980-04-03 1987-08-20 Biogen Idec Ma Inc. Process for producing human fibroblast interferon-like polypeptides using recombinant dna
DE3176011D1 (en) * 1980-06-12 1987-04-23 Japan Found Cancer Plasmid
US4874702A (en) * 1980-09-08 1989-10-17 Biogen, Inc. Vectors and methods for making such vectors and for expressive cloned genes

Also Published As

Publication number Publication date
GB2098996A (en) 1982-12-01
YU44835B (en) 1991-04-30
NL8104400A (nl) 1982-04-16
AU582110B2 (en) 1989-03-16
OA06908A (fr) 1983-05-31
FI812993A7 (fi) 1982-03-26
ES515032A0 (es) 1983-06-01
FR2490675A1 (fr) 1982-03-26
ES8307297A1 (es) 1983-07-01
IT8124109A0 (it) 1981-09-23
MTP900B (en) 1985-02-28
MY8600634A (en) 1986-12-31
PT73728B (en) 1984-05-08
CA1341569C (en) 2008-03-25
CH651309A5 (de) 1985-09-13
DD209652A5 (de) 1984-05-16
DK423381A (da) 1982-03-26
FI812993L (fi) 1982-03-26
NZ198445A (en) 1984-05-31
ATA410381A (de) 1985-11-15
PT73728A (en) 1981-10-01
IE812224L (en) 1982-03-25
AT380694B (de) 1986-06-25
GR81946B (cg-RX-API-DMAC10.html) 1984-12-12
GB2098996B (en) 1985-02-06
ZW23981A1 (en) 1982-04-28
EP0048970A3 (en) 1982-08-18
DE3138096A1 (de) 1982-06-09
US5460811A (en) 1995-10-24
MC1423A1 (fr) 1982-10-18
CH656388A5 (de) 1986-06-30
ES8306324A1 (es) 1983-06-01
EP0048970A2 (en) 1982-04-07
ES515033A0 (es) 1983-06-01
ES8306325A1 (es) 1983-06-01
IL63916A0 (en) 1981-12-31
LU83648A1 (de) 1983-06-08
DD209477A5 (de) 1984-05-09
HK43686A (en) 1986-06-20
IE51679B1 (en) 1987-02-04
YU229781A (en) 1984-02-29
BR8106137A (pt) 1982-06-15
AU7564981A (en) 1982-04-01
PL233194A1 (en) 1983-07-18
KE3630A (en) 1986-05-16
DD202085A5 (de) 1983-08-24
NO813248L (no) 1982-03-26
IT1139487B (it) 1986-09-24
ES505742A0 (es) 1983-07-01
FR2490675B1 (fr) 1985-11-15

Similar Documents

Publication Publication Date Title
SE8105657L (sv) Mikrobiell framstellning av humanfibroblastinterferon
GB2090258B (en) Hybrid leukocyte interferon
HK49285A (en) Interferons and process for their preparation
FI831818A0 (fi) Mikrobiologiskt framstaellda - och -interferoner, dessa interferoner kodande dna-sekvenser, dennagenetiska information innehaollande mikroorganismer och deras framstaellningsfoerfarande
IE822479L (en) Dna molecules encoding certain mammalian proteins
DE3584579D1 (de) Herstellung von polypeptiden mit human-gammainterferon-aktivitaet.
MX9203645A (es) Nuevos interferones de humano y proceso biotecnologico para su produccion.
EP0072541A3 (en) Human leukocyte interferons, process for their microbial production, intermediates therefor and compositions containing them
EP0676413A3 (en) Interferon alpha / beta binding protein, its production and application.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8105657-4